Dauer der Einlagerung autologer Blutstammzellprodukte von Kindern und Jugendlichen mit malignen Erkrankungen

doi:10.1055/s-2005-872545

Klin Padiatr 2005; 217(6): 371-373
DOI: 10.1055/s-2005-872545

Berichte der GPOH

Dauer der Einlagerung autologer Blutstammzellprodukte von Kindern und Jugendlichen mit malignen Erkrankungen

Stellungnahme der Pädiatrischen Arbeitsgemeinschaft für Knochenmark- und Blutstammzelltransplantation (Päd-AG-KBT) und der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)Duration of Storage of Autologous Hematopoietic Stem Cell Products for Children and Adolescents with Malignant Diseases

Abstract

Full Text

References

Literatur

1 Attarian H, Feng Z, Buckner C D, MacLeod B, Rowley S D. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant. 1996; 17 425-430
2 Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling F, Schrappe M, Simon T, Hero B. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncology. 2005; 6 649-658
3 Broxmeyer H E, Srour E F, Hangoc G, Cooper S, Anderson S A, Bodine D M. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA. 2003; 100 645-650
4 Burdach S, Meyer-Bahlburg A, Laws H J, Haase R, Kaik B, Metzner B, Wawer A, Finke R, Göbel U, Haerting J, Pape H, Gadner H, Dunst J, Jürgens H. High-Dose Therapy for Patients with Primary Multifocal and Early Relapsed Ewing's Tumors: Results of Two Consecutive Regimens Assessing the Role of Total-Body Irradiation. J Clin Oncol. 2003; 16 3072-3078
5 Dallorso S, Dini G, Ladenstein R, Cama A, Milanaccio C, Barra S, Cappelli B, Garré G L. Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours. Bone Marrow Transplantation. 2005; 35 S31-S34
6 De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau J L, Ladenstein R, Demirer T, Dini G. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. Br J Cancer. 2005; 93 412-417
7 Donnenberg A D, Koch E K, Griffin D L, Stanczak H M, Kiss J E, Carlos T M, Buchbarker D M, Yeager A M. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002; 4 157-163
8 Franzius C, Bielack S, Flege S, Eckardt J, Sciuk J, Jurgens H, Schober O. High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma. Nuklearmedizin. 2001; 40 215-220
9 Häberle B, Bode U, Schweinitz D. Differenzierte Therapieansätze für Hochrisiko- und Standardrisiko-Hepatoblastome. Klin Pädiatr. 2003; 215 59-165
10 Jahresbericht 2001 des Pädiatrischen Registers für Stammzell-Transplantationen (PRST).
11 Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws H J, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein F G, Schuolz A, Waver A, Zintl F, Graf N. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant. 2002; 30 893-898
12 Kremens B, Wieland R, Reinhard H, Neubert D, Beck J D, Klingebiel T, Bornfeld N, Havers W. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant. 2003; 31 281-284
13 Matthay K K, Villablanca J G, Seeger R C, Stram D O, Harris R E, Ramsay N K, Swift P, Shimada H, Black C T, Brodeur G M, Gerbing R B, Reynolds C P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999; 341 1165-1173
14 Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, Sato K, Klein J P, Gale R P. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant. 1999; 23 395-396
15 Spurr E E, Wiggins N E, Marsden K A, Lowenthal R M, Ragg S J. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology. 2002; 44 210-217
16 Tepmongkol S, Heyman S. 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status. Med Pediatr Oncol. 1999; 32 427-431
17 Wessalowski R, Schneider D T, Mils O, Hannen M, Calaminus G, Engelbrecht V, Pape H, Willers R, Engert J, Harms D, Göbel U. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Pädiatr. 2003; 215 289-360